NCT02671448: Pilot Trial of Homebound Stem Cell Transplantation
Updated: Jul 15, 2022
NCT02671448: Pilot Trial of Homebound Stem Cell Transplantation
NCT02671448: Pilot Trial of Homebound Stem Cell Transplantation
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).
Sponsor
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT02671448
Official Title: Pilot Trial of Homebound Stem Cell Transplantation
First Posted: February 2, 2016
Click here for details on ClinicalTrials.gov
Other: Cessation of continuous maintenance therapy
Behavioral: Home monitoring teleconsult visits
Behavioral: Patient Reported Outcomes (PRO)
Behavioral: Caregiver Reported Outcomes instruments
- New York: Memorial Sloan-Kettering Cancer Center New York
Location
United States, New York
Comentários